Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinomaPayal Kapur; Yair Lotan; Vitaly Margulis; Arthur I Sagalowsky)
Journal of Urology. 2014;191(6):1671-1677.Abstract
Purpose Epithelial-to-mesenchymal transition is thought to have a crucial role in cancer progression and metastatic egress. We evaluated the association of β-catenin, an important mediator of epithelial-to-mesenchymal transition, with pathological parameters and oncologic outcomes in patients with clear cell renal cell carcinoma. Materials and Methods Immunohistochemical staining was performed for β-catenin on tissue microarrays of patients with nonmetastatic clear cell renal cell carcinoma. Membranous and cytoplasmic expression patterns were assessed separately. β-Catenin was considered dysregulated if membranous as well as cytoplasmic expression was abnormal. Groups were compared based on normal vs dysregulated β-catenin. Survival probabilities were assessed by the Kaplan-Meier method. Cox proportional hazard models were used to identify predictors of oncologic outcomes. Results Included in the study were 406 patients with a median followup of 58 months. Of the patients 52 (12.8%) and 25 (6.2%) experienced recurrence and died of clear cell renal cell carcinoma, respectively. β-Catenin was dysregulated in 70 patients (17.2%). Dysregulation was uniformly associated with adverse pathological features, including advanced T stage, larger tumor diameter, nodal positivity, higher Fuhrman grade, tumor thrombus, sarcomatoid features, necrosis and lymphovascular invasion (each p <0.001). Patients with dysregulated β-catenin had inferior recurrence-free and cancer specific survival (each p <0.001). On multivariate analysis adjusting for tumor stage, nodal status and grade dysregulation was an independent predictor of recurrence-free and cancer specific survival (HR 2.2, 95% CI 1.2-3.9, p = 0.008 and HR 2.4, 95% CI 1.1-5.6, p = 0.044, respectively). Conclusions Dysregulation of β-catenin may be an important phenomenon in clear cell renal cell carcinoma carcinogenesis. These findings support further study of β-catenin, and systematic assessment of β-catenin and epithelial-to-mesenchymal transition in clear cell renal cell carcinoma. © 2014 by American Urological Association Educaton and Research, Inc.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Linbo Wang; Jufeng Guo; Qinchuan Wang; Jichun Zhou; Chenpu Xu; Rongyue Teng; Yongxia Chen; Qun Wei; Zhi-Ping LiuJournal of cancer research and clinical oncology. 2014;140(12):1997-2008.
Kaijie Wu; Jinhai Fan; Linlin Zhang; Zhongyun Ning; Jin Zeng; Jiancheng Zhou; Lei Li; Yule Chen; Tingting Zhang; Xinyang Wang; et al.Cellular Signalling. 2012;24(12):2273-2282.
Aparna Vidyasagar; Shannon R. Reese; Omeed Hafez; Ling-Jin Huang; William F. Swain; Lynn M. Jacobson; Jose R. Torrealba; Pierre-Emmanuel Chammas; Nancy A. Wilson; Arjang DjamaliKidney International. 2013;83(1):84-92.
Appears in this Document